Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1985 Oct 12;291(6501):993–996. doi: 10.1136/bmj.291.6501.993

Treatment of chronic heart failure: a review of recent drug trials.

D P Lipkin, P A Poole-Wilson
PMCID: PMC1416963  PMID: 2864977

Full text

PDF
993

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronow W. S., Greenfield R. S., Alimadadian H., Danahy D. T. Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure. Am J Cardiol. 1977 Nov;40(5):789–793. doi: 10.1016/0002-9149(77)90198-9. [DOI] [PubMed] [Google Scholar]
  2. Aronow W. S., Lurie M., Turbow M., Whittaker K., Van Camp S., Hughes D. Effect of prazosin vs placebo on chronic left ventricular heart failure. Circulation. 1979 Feb;59(2):344–350. doi: 10.1161/01.cir.59.2.344. [DOI] [PubMed] [Google Scholar]
  3. Bing O. H., Brooks W. W., Messer J. V. Effects of isoproterenol on heart muscle performance during myocardial hypoxia. J Mol Cell Cardiol. 1972 Aug;4(4):319–328. doi: 10.1016/0022-2828(72)90078-8. [DOI] [PubMed] [Google Scholar]
  4. Cleland J. G., Dargie H. J., Hodsman G. P., Ball S. G., Robertson J. I., Morton J. J., East B. W., Robertson I., Murray G. D., Gillen G. Captopril in heart failure. A double blind controlled trial. Br Heart J. 1984 Nov;52(5):530–535. doi: 10.1136/hrt.52.5.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Colucci W. S., Wynne J., Holman B. L., Braunwald E. Long-term therapy of heart failure with prazosin: a randomized double blind trial. Am J Cardiol. 1980 Feb;45(2):337–344. doi: 10.1016/0002-9149(80)90656-6. [DOI] [PubMed] [Google Scholar]
  6. Conradson T. B., Rydén L., Ahlmark G., Saetre H., Persson S., Nyquist O., Wernersson B. Clinical efficacy of hydralazine in chronic heart failure: one-year double-blind placebo-controlled study. Am Heart J. 1984 Oct;108(4 Pt 1):1001–1006. doi: 10.1016/0002-8703(84)90467-8. [DOI] [PubMed] [Google Scholar]
  7. Currie P. J., Kelly M. J., McKenzie A., Harper R. W., Lim Y. L., Federman J., Anderson S. T., Pitt A. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy. J Am Coll Cardiol. 1984 Jan;3(1):203–209. doi: 10.1016/s0735-1097(84)80449-0. [DOI] [PubMed] [Google Scholar]
  8. Currie P. J., Kelly M. J., Middlebrook K., Federman J., Sainsbury E., Ashley J., Pitt A. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure. Br Heart J. 1984 May;51(5):530–538. doi: 10.1136/hrt.51.5.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. DiBianco R., Shabetai R., Silverman B. D., Leier C. V., Benotti J. R. Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study. J Am Coll Cardiol. 1984 Nov;4(5):855–866. doi: 10.1016/s0735-1097(84)80044-3. [DOI] [PubMed] [Google Scholar]
  10. Dobbs S. M., Kenyon W. I., Dobbs R. J. Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients. Br Med J. 1977 Mar 19;1(6063):749–752. doi: 10.1136/bmj.1.6063.749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Flaim S. F., Weitzel R. L., Zelis R. Mechanism of action of nitroglycerin during exercise in a rat model of heart failure. Improvement of blood flow to the renal, splanchnic, and cutaneous beds. Circ Res. 1981 Aug;49(2):458–468. doi: 10.1161/01.res.49.2.458. [DOI] [PubMed] [Google Scholar]
  12. Fleg J. L., Gottlieb S. H., Lakatta E. G. Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm. Am J Med. 1982 Aug;73(2):244–250. doi: 10.1016/0002-9343(82)90186-3. [DOI] [PubMed] [Google Scholar]
  13. Franciosa J. A., Cohn J. N. Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. Am J Cardiol. 1980 Mar;45(3):648–654. doi: 10.1016/s0002-9149(80)80018-x. [DOI] [PubMed] [Google Scholar]
  14. Franciosa J. A., Goldsmith S. R., Cohn J. N. Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure. Am J Med. 1980 Oct;69(4):559–566. doi: 10.1016/0002-9343(80)90468-4. [DOI] [PubMed] [Google Scholar]
  15. Franciosa J. A., Jordan R. A., Wilen M. M., Leddy C. L. Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial. Circulation. 1984 Jul;70(1):63–68. doi: 10.1161/01.cir.70.1.63. [DOI] [PubMed] [Google Scholar]
  16. Franciosa J. A., Leddy C. L., Wilen M., Schwartz D. E. Relation between hemodynamic and ventilatory responses in determining exercise capacity in severe congestive heart failure. Am J Cardiol. 1984 Jan 1;53(1):127–134. doi: 10.1016/0002-9149(84)90696-9. [DOI] [PubMed] [Google Scholar]
  17. Franciosa J. A., Weber K. T., Levine T. B., Kinasewitz G. T., Janicki J. S., West J., Henis M. M., Cohn J. N. Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo. Am Heart J. 1982 Sep;104(3):587–594. doi: 10.1016/0002-8703(82)90231-9. [DOI] [PubMed] [Google Scholar]
  18. Franciosa J. A., Wilen M. M., Jordan R. A. Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failure. J Am Coll Cardiol. 1985 Jan;5(1):101–107. doi: 10.1016/s0735-1097(85)80090-5. [DOI] [PubMed] [Google Scholar]
  19. Glover D. R., Wathen C. G., Murray R. G., Petch M. C., Muir A. L., Littler W. A. Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo. Br Heart J. 1985 Feb;53(2):208–215. doi: 10.1136/hrt.53.2.208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Harper R. W., Claxton H., Middlebrook K., Anderson S., Pitt A. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure. Med J Aust. 1980 Jul 26;2 (Suppl 1):36–38. [PubMed] [Google Scholar]
  21. Higginbotham M. B., Morris K. G., Bramlet D. A., Coleman R. E., Cobb F. R. Long-term ambulatory therapy with prazosin versus placebo for chronic heart failure: relation between clinical response and left ventricular function at rest and during exercise. Am J Cardiol. 1983 Oct 1;52(7):782–788. doi: 10.1016/0002-9149(83)90415-0. [DOI] [PubMed] [Google Scholar]
  22. Ikram H., Fitzpatrick D. Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy. Lancet. 1981 Sep 5;2(8245):490–493. doi: 10.1016/s0140-6736(81)90881-3. [DOI] [PubMed] [Google Scholar]
  23. Kramer B. L., Massie B. M., Topic N. Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study. Circulation. 1983 Apr;67(4):807–816. doi: 10.1161/01.cir.67.4.807. [DOI] [PubMed] [Google Scholar]
  24. Lambertz H., Meyer J., Erbel R. Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure. Circulation. 1984 Feb;69(2):298–305. doi: 10.1161/01.cir.69.2.298. [DOI] [PubMed] [Google Scholar]
  25. Lee D. C., Johnson R. A., Bingham J. B., Leahy M., Dinsmore R. E., Goroll A. H., Newell J. B., Strauss H. W., Haber E. Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med. 1982 Mar 25;306(12):699–705. doi: 10.1056/NEJM198203253061202. [DOI] [PubMed] [Google Scholar]
  26. Leier C. V., Huss P., Magorien R. D., Unverferth D. V. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Circulation. 1983 Apr;67(4):817–822. doi: 10.1161/01.cir.67.4.817. [DOI] [PubMed] [Google Scholar]
  27. Likoff M. J., Weber K. T., Andrews V., Janicki J. S., Sutton M. S., Wilson H., Rocci M. L., Jr Amrinone in the treatment of chronic cardiac failure. J Am Coll Cardiol. 1984 May;3(5):1282–1290. doi: 10.1016/s0735-1097(84)80189-8. [DOI] [PubMed] [Google Scholar]
  28. Markham R. V., Jr, Corbett J. R., Gilmore A., Pettinger W. A., Firth B. G. Efficacy of prazosin in the management of chronic congestive heart failure: a 6-month randomized, double-blind, placebo-controlled study. Am J Cardiol. 1983 May 1;51(8):1346–1352. doi: 10.1016/0002-9149(83)90310-7. [DOI] [PubMed] [Google Scholar]
  29. Packer M., Medina N., Yushak M. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure. Circulation. 1984 Dec;70(6):1038–1047. doi: 10.1161/01.cir.70.6.1038. [DOI] [PubMed] [Google Scholar]
  30. Roubin G. S., Choong C. Y., Devenish-Meares S., Sadick N. N., Fletcher P. J., Kelly D. T., Harris P. J. Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol. Circulation. 1984 May;69(5):955–962. doi: 10.1161/01.cir.69.5.955. [DOI] [PubMed] [Google Scholar]
  31. Sharpe D. N., Murphy J., Coxon R., Hannan S. F. Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study. Circulation. 1984 Aug;70(2):271–278. doi: 10.1161/01.cir.70.2.271. [DOI] [PubMed] [Google Scholar]
  32. Swedberg K., Hjalmarson A., Waagstein F., Wallentin I. Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy. Br Heart J. 1980 Aug;44(2):134–142. doi: 10.1136/hrt.44.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Swedberg K., Hjalmarson A., Waagstein F., Wallentin I. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J. 1980 Aug;44(2):117–133. doi: 10.1136/hrt.44.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Swedberg K., Hjalmarson A., Waagstein F., Wallentin I. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet. 1979 Jun 30;1(8131):1374–1376. doi: 10.1016/s0140-6736(79)92010-5. [DOI] [PubMed] [Google Scholar]
  35. Waagstein F., Hjalmarson A., Varnauskas E., Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1975 Oct;37(10):1022–1036. doi: 10.1136/hrt.37.10.1022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Weber K. T., Andrews V., Janicki J. S., Likoff M., Reichek N. Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure. Circulation. 1982 Dec;66(6):1262–1267. doi: 10.1161/01.cir.66.6.1262. [DOI] [PubMed] [Google Scholar]
  37. Weber K. T., Kinasewitz G. T., Janicki J. S., Fishman A. P. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation. 1982 Jun;65(6):1213–1223. doi: 10.1161/01.cir.65.6.1213. [DOI] [PubMed] [Google Scholar]
  38. Weber K. T., Kinasewitz G. T., West J. S., Janicki J. S., Reichek N., Fishman A. P. Long-term vasodilator therapy with trimazosin in chronic cardiac failure. N Engl J Med. 1980 Jul 31;303(5):242–250. doi: 10.1056/NEJM198007313030502. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES